Michael Scott Sherman is SVP and General Counsel at Genesis Healthcare, Inc. (GEN). They have made 8 open-market trades across 1 company since 2016, most recently 2021-05-15.
CIK 0001631386
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GEN | 741,202 | $22.9M |
Shares reported on the most recent Form 4, priced at the 2021-05-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GEN | SELL | 2019-06-12 | 2019-06-14 | $1.17 | $9K | +5.2% | +15.2% | +23.8% |
| GEN | SELL | 2019-06-03 | 2019-06-05 | $1.16 | $6K | +3.5% | +31.0% | +20.4% |
| GEN | SELL | 2019-05-20 | 2019-05-22 | $1.20 | $8K | -5.7% | +4.1% | +18.7% |
| GEN | SELL | 2018-06-12 | 2018-06-13 | $2.28 | $8K | -4.2% | +1.4% | -6.4% |
| GEN | SELL | 2018-06-05 | 2018-06-07 | $2.19 | $13K | -1.3% | +1.4% | -6.5% |
| GEN | SELL | 2017-06-14 | 2017-06-15 | $1.73 | $7K | -0.8% | +7.7% | +16.8% |
| GEN | SELL | 2017-06-07 | 2017-06-09 | $1.61 | $3K | -1.7% | -1.5% | +3.9% |
| GEN | SELL | 2016-06-08 | 2016-06-09 | $1.72 | $3K | +21.8% | +21.1% | +45.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.